General
Preferred name
Ridinilazole
Synonyms
SMT19969 ()
SMT-19969 ()
Smt19969 ()
Ridinilazol ()
P&D ID
PD101265
CAS
308362-25-6
Tags
available
drug candidate
Drug Status
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Ridinilazole (SMT19969) is an oral small molecule antibacterial that was developed to treat Clostridioides difficile infection. It exhibited potent bactericidal activity against all strains of C. difficile tested in vitro, and in in vivo models . (GtoPdb)
Compound Sets
8
AdooQ Bioactive Compound Library
A21068
ChEMBL Drugs
CHEMBL3753858
Drug Repurposing Hub
DrugBank
DB15308
Guide to Pharmacology
10853
MedChem Express Bioactive Compound Library
HY-16753
ReFrame library
TargetMol Bioactive Compound Library
T16748
External IDs
23
Properties
(calculated by RDKit )
Molecular Weight
388.14
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
6
Aromatic Ring Count
6
cLogP
5.23
TPSA
83.14
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Microbiology&virology
Anti-infection
Target
Antibacterial
Bacterial
Source data